Synopsis
Synopsis
0
VMF
0
Australia
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


| Molecular Weight | 397.4 g/mol |
|---|---|
| Molecular Formula | C18H24NO7P |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 1 |
| Exact Mass | 397.12903910 g/mol |
| Monoisotopic Mass | 397.12903910 g/mol |
| Topological Polar Surface Area | 120 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 558 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 5 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
NDC Package Code : 49812-0051
Start Marketing Date : 2019-09-06
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
NDC Package Code : 51634-0999
Start Marketing Date : 1986-06-06
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Siegfried – A global CDMO delivering integrated pharmaceutical development and manufacturing solutions.
NDC Package Code : 0792-0644
Start Marketing Date : 2007-01-29
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0406-1550
Start Marketing Date : 1986-12-30
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 0406-1548
Start Marketing Date : 1973-06-30
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 0406-1561
Start Marketing Date : 1975-08-15
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 38779-0679
Start Marketing Date : 2014-08-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT

NDC Package Code : 51927-1013
Start Marketing Date : 2002-07-19
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...

NDC Package Code : 51927-0335
Start Marketing Date : 2024-04-09
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...

NDC Package Code : 61960-0380
Start Marketing Date : 2019-10-15
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]About the Company : EUROAPI focuses on reinventing active ingredient solutions to sustainably meet the needs of customers and patients worldwide. The company is a leading API player with a portfolio o...
About the Company : Aspen API is a cooperative entity formed by Aspen Oss in the Netherlands and Fine Chemicals Corporation in South Africa. The company supplies a broad portfolio of over 50 high-qual...
About the Company : Temad Co., established in 1997, is one of Iran's largest API producers and an innovative manufacturer of narcotic and non-narcotic products in the Middle East. It complies with Ira...
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
About the Company : Noramco, founded in 1979, specializes in developing and manufacturing APIs for opioid and non-opioid products. It excels in controlled substance development, offering supply-chain ...
About the Company : Alcaliber is a benchmark in the World Drug Industry both in terms of quality and innovation, integrity and commitment to our customers. We are a leading company: in 2014 we were th...

About the Company : Chr. Olesen Synthesis is a Danish manufacturer of APIs and advanced intermediates. Chr. Olesen Synthesis was established in 2012 after the Chr. Olesen Group acquisition of the mult...

About the Company : Danesh Kimia Pharmed Co. was established on 2011 by industrial and university researchers in order to invest on the production of new pharmaceutical molecules and their ready to us...

About the Company : We are an Italian company that import and export goods and services to all around the world. Our target is to obtain the best quality goods and services to satisfy the requirements...

About the Company : Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to addr...

About the Company : Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to addr...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Withdrawn
Registration Country : Malta
Paracetamol; Codeine Phosphate Hemihydrate
Brand Name : Solpadol Caplets
Dosage Form : Tablet
Dosage Strength : 500MG; 30MG
Packaging :
Approval Date : 2009-05-29
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Withdrawn
Registration Country : Malta
Paracetamol; Codeine Phosphate Hemihydrate
Brand Name : Solpadol Caplets
Dosage Form : Tablet
Dosage Strength : 500MG; 30MG
Packaging :
Approval Date : 2019-08-05
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : NARCOTICS (CDSA I)
Registration Country : Canada
Brand Name : MERSYNDOL WITH CODEINE
Dosage Form : TABLET
Dosage Strength : 8MG
Packaging : 24/100
Approval Date :
Application Number : 2047667
Regulatory Info : NARCOTICS (CDSA I)
Registration Country : Canada
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : DISCN
Registration Country : USA
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Brand Name : FIORINAL W/CODEINE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 325MG;50MG;40MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1990-10-26
Application Number : 19429
Regulatory Info : DISCN
Registration Country : USA
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Regulatory Info : RX
Registration Country : USA
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Brand Name : BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 325MG;50MG;40MG;30MG
Packaging :
Approval Date : 2001-11-30
Application Number : 75231
Regulatory Info : RX
Registration Country : USA
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Regulatory Info : RX
Registration Country : USA
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Brand Name : BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 325MG;50MG;40MG;30MG
Packaging :
Approval Date : 2004-06-10
Application Number : 76560
Regulatory Info : RX
Registration Country : USA
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Regulatory Info : RX
Registration Country : USA
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Brand Name : BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 300MG;50MG;40MG;30MG
Packaging :
Approval Date : 2012-07-19
Application Number : 76560
Regulatory Info : RX
Registration Country : USA
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Ibucod
Dosage Form : TAB
Dosage Strength : 10mg
Packaging : 18X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Ibucod
Dosage Form : TAB
Dosage Strength : 10mg
Packaging : 30X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Mybulen Suspension
Dosage Form : SUS
Dosage Strength : 10mg/10ml
Packaging : 100X1mg/10ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Regulatory Info :
Registration Country : Iran
Guaifenesin; Pseudoephedrine Hydrochloride; Codeine Phosphate
Brand Name : Expectorant Codeine
Dosage Form : Syrup
Dosage Strength : 100MG; 30MG; 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Packaging :
Regulatory Info :
Guaifenesin; Pseudoephedrine Hydrochloride; Codeine Phosphate
Dosage : Syrup
Dosage Strength : 100MG; 30MG; 10MG
Brand Name : Expectorant Codeine
Approval Date :
Application Number :
Registration Country : Iran
Regulatory Info :
Registration Country : Iran
Guaifenesin; Codeine Phosphate
Brand Name : Guaicodin
Dosage Form : Syrup
Dosage Strength : 100MG; 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Packaging :
Regulatory Info :
Guaifenesin; Codeine Phosphate
Dosage : Syrup
Dosage Strength : 100MG; 10MG
Brand Name : Guaicodin
Approval Date :
Application Number :
Registration Country : Iran
Regulatory Info :
Registration Country : India
Codeine Phosphate; Paracetamol
Brand Name : Codeine Phosphate; Par...
Dosage Form : Tablet
Dosage Strength : 8MG; 500MG
Packaging : Pack Size 10x10
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : Pack Size 10x10
Regulatory Info :
Codeine Phosphate; Paracetamol
Dosage : Tablet
Dosage Strength : 8MG; 500MG
Brand Name : Codeine Phosphate; Par...
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Codeine Phosphate; Paracetamol
Brand Name : Codeine Phosphate; Par...
Dosage Form : Tablet
Dosage Strength : 30MG; 500MG
Packaging : Pack Size 10x10
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : Pack Size 10x10
Regulatory Info :
Codeine Phosphate; Paracetamol
Dosage : Tablet
Dosage Strength : 30MG; 500MG
Brand Name : Codeine Phosphate; Par...
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Acetaminophen; Butalbital; Caffeine; Codeine Phosphate
Brand Name : Acetaminophen; Butalbi...
Dosage Form : Tablet
Dosage Strength : 50MG; 325MG; 40MG; 30M...
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Acetaminophen; Butalbital; Caffeine; Codeine Phosphate
Dosage : Tablet
Dosage Strength : 50MG; 325MG; 40MG; 30M...
Brand Name : Acetaminophen; Butalbi...
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Aspirin; Butalbital; Caffeine; Codeine Phosphate
Brand Name : Aspirin; Butalbital; C...
Dosage Form : Tablet
Dosage Strength : 50MG; 325MG; 40MG; 30M...
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Aspirin; Butalbital; Caffeine; Codeine Phosphate
Dosage : Tablet
Dosage Strength : 50MG; 325MG; 40MG; 30M...
Brand Name : Aspirin; Butalbital; C...
Approval Date :
Application Number :
Registration Country : India
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : Brazil
Brand Name : CODEIN
Dosage Form : INJECTION
Dosage Strength : 30MG/ML
Packaging : 25 AMPS X 2 ML
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Brazil

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : 25 AMPS X 2 ML
Regulatory Info : Generic
Dosage : INJECTION
Dosage Strength : 30MG/ML
Brand Name : CODEIN
Approval Date :
Application Number :
Registration Country : Brazil

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Specs: USP
Registration Country : U.S.A
Acetaminophen/Paracetamol; Codeine Phosphate
Brand Name :
Dosage Form : Tablet
Dosage Strength : 300MG; 30MG
Packaging : Size: 30s, 100s, 1000s, 100 U.D. (For Size 100 U.D. - Unit Dose Packaging-ten 2x5 blister cards)
Approval Date :
Application Number :
Regulatory Info : Specs: USP
Registration Country : U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : Size: 30s, 100s, 1000s, 100 U.D. (For Size 100 U.D. - Unit Dose Packaging-ten 2x5 blister cards)
Regulatory Info : Specs: USP
Acetaminophen/Paracetamol; Codeine Phosphate
Dosage : Tablet
Dosage Strength : 300MG; 30MG
Brand Name :
Approval Date :
Application Number :
Registration Country : U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Paracetamol; Codeine Phosphate
Brand Name :
Dosage Form : Tablet
Dosage Strength : 500MG; 9.6MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Paracetamol; Codeine Phosphate
Dosage : Tablet
Dosage Strength : 500MG; 9.6MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Brand Name : VERCOD
Dosage Form : Tablet
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 30MG
Brand Name : VERCOD
Approval Date :
Application Number :
Registration Country : India

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
64
PharmaCompass offers a list of Codeine Phosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Codeine Phosphate manufacturer or Codeine Phosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Codeine Phosphate manufacturer or Codeine Phosphate supplier.
A FIORINAL W/CODEINE-3 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of FIORINAL W/CODEINE-3, including repackagers and relabelers. The FDA regulates FIORINAL W/CODEINE-3 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. FIORINAL W/CODEINE-3 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of FIORINAL W/CODEINE-3 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A FIORINAL W/CODEINE-3 supplier is an individual or a company that provides FIORINAL W/CODEINE-3 active pharmaceutical ingredient (API) or FIORINAL W/CODEINE-3 finished formulations upon request. The FIORINAL W/CODEINE-3 suppliers may include FIORINAL W/CODEINE-3 API manufacturers, exporters, distributors and traders.
click here to find a list of FIORINAL W/CODEINE-3 suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A FIORINAL W/CODEINE-3 DMF (Drug Master File) is a document detailing the whole manufacturing process of FIORINAL W/CODEINE-3 active pharmaceutical ingredient (API) in detail. Different forms of FIORINAL W/CODEINE-3 DMFs exist exist since differing nations have different regulations, such as FIORINAL W/CODEINE-3 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A FIORINAL W/CODEINE-3 DMF submitted to regulatory agencies in the US is known as a USDMF. FIORINAL W/CODEINE-3 USDMF includes data on FIORINAL W/CODEINE-3's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The FIORINAL W/CODEINE-3 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of FIORINAL W/CODEINE-3 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The FIORINAL W/CODEINE-3 Drug Master File in Japan (FIORINAL W/CODEINE-3 JDMF) empowers FIORINAL W/CODEINE-3 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the FIORINAL W/CODEINE-3 JDMF during the approval evaluation for pharmaceutical products. At the time of FIORINAL W/CODEINE-3 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of FIORINAL W/CODEINE-3 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a FIORINAL W/CODEINE-3 Drug Master File in Korea (FIORINAL W/CODEINE-3 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of FIORINAL W/CODEINE-3. The MFDS reviews the FIORINAL W/CODEINE-3 KDMF as part of the drug registration process and uses the information provided in the FIORINAL W/CODEINE-3 KDMF to evaluate the safety and efficacy of the drug.
After submitting a FIORINAL W/CODEINE-3 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their FIORINAL W/CODEINE-3 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of FIORINAL W/CODEINE-3 suppliers with KDMF on PharmaCompass.
A FIORINAL W/CODEINE-3 CEP of the European Pharmacopoeia monograph is often referred to as a FIORINAL W/CODEINE-3 Certificate of Suitability (COS). The purpose of a FIORINAL W/CODEINE-3 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of FIORINAL W/CODEINE-3 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of FIORINAL W/CODEINE-3 to their clients by showing that a FIORINAL W/CODEINE-3 CEP has been issued for it. The manufacturer submits a FIORINAL W/CODEINE-3 CEP (COS) as part of the market authorization procedure, and it takes on the role of a FIORINAL W/CODEINE-3 CEP holder for the record. Additionally, the data presented in the FIORINAL W/CODEINE-3 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the FIORINAL W/CODEINE-3 DMF.
A FIORINAL W/CODEINE-3 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. FIORINAL W/CODEINE-3 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of FIORINAL W/CODEINE-3 suppliers with CEP (COS) on PharmaCompass.
A FIORINAL W/CODEINE-3 written confirmation (FIORINAL W/CODEINE-3 WC) is an official document issued by a regulatory agency to a FIORINAL W/CODEINE-3 manufacturer, verifying that the manufacturing facility of a FIORINAL W/CODEINE-3 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting FIORINAL W/CODEINE-3 APIs or FIORINAL W/CODEINE-3 finished pharmaceutical products to another nation, regulatory agencies frequently require a FIORINAL W/CODEINE-3 WC (written confirmation) as part of the regulatory process.
click here to find a list of FIORINAL W/CODEINE-3 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing FIORINAL W/CODEINE-3 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for FIORINAL W/CODEINE-3 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture FIORINAL W/CODEINE-3 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain FIORINAL W/CODEINE-3 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a FIORINAL W/CODEINE-3 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of FIORINAL W/CODEINE-3 suppliers with NDC on PharmaCompass.
FIORINAL W/CODEINE-3 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of FIORINAL W/CODEINE-3 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right FIORINAL W/CODEINE-3 GMP manufacturer or FIORINAL W/CODEINE-3 GMP API supplier for your needs.
A FIORINAL W/CODEINE-3 CoA (Certificate of Analysis) is a formal document that attests to FIORINAL W/CODEINE-3's compliance with FIORINAL W/CODEINE-3 specifications and serves as a tool for batch-level quality control.
FIORINAL W/CODEINE-3 CoA mostly includes findings from lab analyses of a specific batch. For each FIORINAL W/CODEINE-3 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
FIORINAL W/CODEINE-3 may be tested according to a variety of international standards, such as European Pharmacopoeia (FIORINAL W/CODEINE-3 EP), FIORINAL W/CODEINE-3 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (FIORINAL W/CODEINE-3 USP).